The 2020 Annual General Meeting (AGM) of Allergy Therapeutics plc is due to be held electronically on Tuesday 8 December 2020 at 2:00 p.m.
We remain committed to ensuring that shareholders can exercise their right to vote and ask questions at the upcoming AGM. However, in light of the compulsory government measures in force in response to the COVID-19 pandemic, and with the health and well-being of our colleagues, shareholders and the wider community in which we operate in mind, the AGM this year will be run as an electronic meeting.
Voting on the business of the meeting will be conducted by way of a poll, to reflect the proxy voting instructions received. Shareholders must register their vote in advance by appointing the chair of the meeting as their proxy and giving voting instructions.
Please register your proxy vote no later than 2.00 p.m. on 6 December 2020 via our registrar’s website www.signalshares.com, or you may request a paper proxy form from our registrar, or if you are a CREST member via the CREST electronic appointment service. Further details of how to register your proxy vote are contained within the notes to the Notice of Meeting.
The Board is arranging a listen-only conference call facility to allow shareholders to dial in to the AGM and follow proceedings remotely. The conference call details will be published on our website homepage approximately 72 hours before the date and time of the meeting
While there will be no Board presentation or live Q&A session with the Board, shareholders can submit questions for the Board in advance of the AGM by email to investor.relations@allergytherapeutics.com and the Board will endeavour to answer such questions at the meeting.
Documents relating to the 2020 AGM can be downloaded below: